🏥 Health 1d ago

View Channel →

0 0 Save Read Full Article Source ↗ 👁 0 💬 0

(MedPage Today) -- NEW ORLEANS -- Once-daily orforglipron (Foundayo) improved outcomes in adults with type 2 diabetes and inadequate glycemic control, the international ACHIEVE-5 trial showed.
In patients already taking background insulin glargine...

Sign in to join the discussion

Helping Teen Girls Dream Big Without Burning Out

Psychology Today: The Latest · 5h ago

Quick Fixes for Anxiety

Psychology Today: The Latest · 5h ago

Large Study Links GLP-1s to Lower Risk of Multiple Cancers

MedPageToday.com - medical news for physicians · 5h ago

We Built the Machine, Then Blamed the Kids for Unplugging

Psychology Today: The Latest · 6h ago

GLP-1, Amylin Analog Combo Cuts Blood Sugar, Weight in Diabetes Trials

MedPageToday.com - medical news for physicians · 6h ago

Are Older People Really Happier Than Younger People?

Psychology Today: The Latest · 6h ago